Drug name - Klisyri

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8980890 ALMIRALL Compositions and methods of treating cell proliferation disorders
Dec, 2025

(3 years from now)

US8236799 ALMIRALL Biaryl compositions and methods for modulating a kinase cascade
Dec, 2025

(3 years from now)

US7300931 ALMIRALL Compositions for treating cell proliferation disorders
Feb, 2026

(3 years from now)

US7851470 ALMIRALL Composition and methods for modulating a kinase cascade
Feb, 2029

(6 years from now)

US10669236 ALMIRALL Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide
Sep, 2038

(15 years from now)

CN103274961A ALMIRALL Compounds And Methods For Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

CN103274961B ALMIRALL Compounds And Methods For Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

CN101184734A ALMIRALL Compound And Method For Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

CN101184734B ALMIRALL Compounds And Methods For Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

CN101595084A ALMIRALL Biaryl Compositions And Methods For Modulating A Kinase Cascade
Jun, 2027

(4 years from now)

CN101595084B ALMIRALL Biaryl Compositions And Methods For Modulating A Kinase Cascade
Jun, 2027

(4 years from now)

CN101616915A ALMIRALL Composition And Methods For Modulating A Kinase Cascade
Dec, 2027

(5 years from now)

CN101616915B ALMIRALL A Method And Composition Of A Kinase Cascade
Dec, 2027

(5 years from now)

CN101687798A ALMIRALL Process For Preparation Of Compositions For Modulating A Kinase Cascade And Methods Of Use Thereof
May, 2028

(5 years from now)

CN101687798B ALMIRALL Process For Preparing Modified Kinase Cascade Composition And Using Method Thereof
May, 2028

(5 years from now)

IN339823B ALMIRALL Compounds For Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

IN201400549P2 ALMIRALL Compounds For Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

IN259746B ALMIRALL Compositions And Methods Of Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

IN200702504P2 ALMIRALL Compositions And Methods Of Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

EP1836169B1 ALMIRALL Compositions And Methods Of Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

EP1836169B9 ALMIRALL Compositions And Methods Of Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

EP1836169A2 ALMIRALL Compositions And Methods Of Treating Cell Proliferation Disorders
Dec, 2025

(3 years from now)

EP2041071A2 ALMIRALL Biaryl Compositions And Methods For Modulating A Kinase Cascade
Jun, 2027

(4 years from now)

EP2041071B1 ALMIRALL Biaryl Compositions And Methods For Modulating A Kinase Cascade
Jun, 2027

(4 years from now)

EP2114934B1 ALMIRALL Composition And Methods For Modulating A Kinase Cascade
Dec, 2027

(5 years from now)

EP2114934A1 ALMIRALL Composition And Methods For Modulating A Kinase Cascade
Dec, 2027

(5 years from now)

EP2155681A1 ALMIRALL Process For The Preparation Of Compositions For Modulating A Kinase Cascade And Methods Of Use Thereof
May, 2028

(5 years from now)

EP2155681B1 ALMIRALL Process For The Preparation Of Compositions For Modulating A Kinase Cascade And Methods Of Use Thereof
May, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10323001 ALMIRALL Compositions for modulating a kinase cascade and methods of use thereof Dec, 2027

(5 years from now)

US10617693 ALMIRALL Methods of treating and/or preventing actinic keratosis Mar, 2038

(15 years from now)

Drugs and Companies using TIRBANIBULIN ingredient

Treatment: Topical treatment of actinic keratosis of the face or scalp

Dosage: OINTMENT;TOPICAL

More Information on Dosage
Strength Dosage Availability
1% OINTMENT;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.